Cubist Announces Submission of New Drug Application for Investigational Antibiotic Ceftolozane/tazobactam
April 21, 2014 at 08:31 AM EDT
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and ...